Alvotech ( ALVO) - Stock Earnings
ALVO Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 12, 2026, midnight | — / — | — | — / — | — |
ALVO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | 32.0 million USD | 173.2 million USD |
| 2025Q3 | -5.2 million USD | 114.0 million USD |
| 2025Q4 | -108.6 million USD | 166.4 million USD |
| 2026Q3 Est. | — | — |
ALVO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -551.7 million USD | 91.4 million USD |
| 2024 | -231.9 million USD | 489.7 million USD |
| 2025 | 27.9 million USD | 586.3 million USD |
| 2026 Est. | — | — |
ALVO
Price: $3.52
52 week price:
Earnings Per Share: 0.10 USD
P/E Ratio: 35.50
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 1.2 billion